401 Stock Overview
An investment holding company, engages in pharmaceutical wholesale and distribution business in the Mainland China and Hong Kong. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Wanjia Group Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.05 |
| 52 Week High | HK$0.095 |
| 52 Week Low | HK$0.042 |
| Beta | 0.27 |
| 1 Month Change | -19.35% |
| 3 Month Change | -30.56% |
| 1 Year Change | -41.86% |
| 3 Year Change | -68.75% |
| 5 Year Change | -76.19% |
| Change since IPO | -98.77% |
Recent News & Updates
Is Wanjia Group Holdings (HKG:401) Using Debt In A Risky Way?
Nov 29
Wanjia Group Holdings Limited's (HKG:401) Shares Leap 63% Yet They're Still Not Telling The Full Story
Sep 30Recent updates
Is Wanjia Group Holdings (HKG:401) Using Debt In A Risky Way?
Nov 29Wanjia Group Holdings Limited's (HKG:401) Shares Leap 63% Yet They're Still Not Telling The Full Story
Sep 30It Looks Like Wanjia Group Holdings Limited's (HKG:401) CEO May Expect Their Salary To Be Put Under The Microscope
Sep 06Investors Give Wanjia Group Holdings Limited (HKG:401) Shares A 31% Hiding
Jul 30Investors Continue Waiting On Sidelines For Wanjia Group Holdings Limited (HKG:401)
May 22Slammed 36% Wanjia Group Holdings Limited (HKG:401) Screens Well Here But There Might Be A Catch
Feb 02Wanjia Group Holdings (HKG:401) Will Be Looking To Turn Around Its Returns
Oct 05Wanjia Group Holdings Limited's (HKG:401) Popularity With Investors Under Threat As Stock Sinks 34%
Aug 02Wanjia Group Holdings (HKG:401) Might Have The Makings Of A Multi-Bagger
Jun 24Wanjia Group Holdings (HKG:401) Is Looking To Continue Growing Its Returns On Capital
Mar 09There's Been No Shortage Of Growth Recently For Wanjia Group Holdings' (HKG:401) Returns On Capital
Nov 23Shareholder Returns
| 401 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | -16.7% | 0.9% | 1.1% |
| 1Y | -41.9% | -20.9% | 17.6% |
Return vs Industry: 401 underperformed the Hong Kong Healthcare industry which returned -20.9% over the past year.
Return vs Market: 401 underperformed the Hong Kong Market which returned 17.6% over the past year.
Price Volatility
| 401 volatility | |
|---|---|
| 401 Average Weekly Movement | 11.1% |
| Healthcare Industry Average Movement | 8.4% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in HK Market | 17.8% |
| 10% least volatile stocks in HK Market | 3.9% |
Stable Share Price: 401 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 401's weekly volatility has decreased from 16% to 11% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 155 | Jia Jun Wang | www.wanjia-gp.com |
Wanjia Group Holdings Limited, an investment holding company, engages in pharmaceutical wholesale and distribution business in the Mainland China and Hong Kong. It also offers hemodialysis treatment and consultancy services. The company sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics.
Wanjia Group Holdings Limited Fundamentals Summary
| 401 fundamental statistics | |
|---|---|
| Market cap | HK$28.01m |
| Earnings (TTM) | -HK$35.67m |
| Revenue (TTM) | HK$171.41m |
0.2x
P/S Ratio-0.8x
P/E RatioIs 401 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 401 income statement (TTM) | |
|---|---|
| Revenue | HK$171.41m |
| Cost of Revenue | HK$116.91m |
| Gross Profit | HK$54.50m |
| Other Expenses | HK$90.18m |
| Earnings | -HK$35.67m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.064 |
| Gross Margin | 31.80% |
| Net Profit Margin | -20.81% |
| Debt/Equity Ratio | 16.0% |
How did 401 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 09:06 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Wanjia Group Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|